PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'OB/GYN and Women\'s Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.\', \'Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.\', \'Center for Bioethics, Cleveland Clinic, Cleveland, Ohio, USA.\', \'Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.\', \'Department of OB/GYN, MetroHealth Medical Center, Cleveland, Ohio, USA.\', \'Department of OB/GYN, Indiana University, Indianapolis, Indiana, USA.\', \'Center for Patient Experience, Cleveland Clinic, Cleveland, Ohio, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/pd.5902
?:hasPublicationType
?:journal
  • Prenatal diagnosis
is ?:pmid of
?:pmid
?:pmid
  • 33569794
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.139
?:rankingScore_hIndex
  • 88
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of the emergence of COVID-19 on women\'s prenatal genetic testing decisions.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all